• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Agfa sees increased sales in 1998

Article

Bayer’s Agfa division reported its fiscal 1998 results last month. Agfa saw sales rise by 5% to DM 8.5 billion ($4.7 billion), as compared with DM 8.1 billion ($4.5 billion) in 1997. Its operating profit declined by 12.9% to $2.7 million, which the

Bayer’s Agfa division reported its fiscal 1998 results last month. Agfa saw sales rise by 5% to DM 8.5 billion ($4.7 billion), as compared with DM 8.1 billion ($4.5 billion) in 1997. Its operating profit declined by 12.9% to $2.7 million, which the company attributed to the Asian financial crisis.

Sales in Agfa’s technical imaging systems division climbed 8% in 1998 as compared with 1997, from $993 million to $1 billion. The group’s medical business unit contributed about three-quarters of the division’s sales, Bayer said. In January, Agfa moved to acquire Sterling Diagnostic Imaging (SCAN 1/20/99), and the purchase should be completed this spring, according to the company.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.